- Home
- RBKB vs NRXP Comparison
RBKB vs NRXP Comparison
Compare RBKB & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RBKB | NRXP |
|---|---|---|
| Founded | 1860 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.5M | 181.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RBKB | NRXP |
|---|---|---|
| Price | $17.38 | $4.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | 45.2K | ★ 910.8K |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 215.00 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $2,984,000.00 | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | $85.35 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.41 | $1.65 |
| 52 Week High | $17.99 | $5.06 |
Technical Indicators
Market Signals| Indicator | RBKB | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 66.38 | 53.21 |
| Support Level | $15.10 | $1.83 |
| Resistance Level | $17.92 | $4.20 |
| Average True Range (ATR) | 0.22 | 0.28 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 100.00 | 41.14 |
Price Performance
Historical ComparisonAbout RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.